You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (8)

Journals (0)

1-8 of 8 results for XPO1

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Synergistic effects of XPO1 inhibitors combined with CD19 CAR-T cells in TP53-mutated DLBCL

Retricted access

Research article

First published 2026

Synergistic effects of XPO1 inhibitors combined with CD19 CAR-T cells in TP53-mutated DLBCL

Zhimin Bai, Xiaoyu Huang, Xinfeng Wang [...]

Tumori Journal

Select article: The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturbation of the DNA Damage Response

Open access

Research article

First published 2023

The Therapeutic Synergy of Selinexor and Venetoclax in Mantle Cell Lymphoma Through Induction of DNA Damage and Perturbation of the DNA Damage Response

Sheng Yuan, Wei Zuo, Tingting Liu [...]

Technology in Cancer Research & Treatment

Select article: Overview of systemic therapy options in liposarcoma,with a focus on the activity of selinexor,a selective inhibitor of nuclear export in dedifferentiated liposarcoma

Open access

Review article

First published 2022

Overview of systemic therapy options in liposarcoma,with a focus on the activity of selinexor,a selective inhibitor of nuclear export in dedifferentiated liposarcoma

Prapassorn Thirasastr, Neeta Somaiah

Therapeutic Advances in Medical Oncology

Select article: Treatment of multiple myeloma with selinexor: a review

Open access

Review article

First published 2024

Treatment of multiple myeloma with selinexor: a review

Qianlei Huang, Ranran Zhao, Lu Xu [...]

Therapeutic Advances in Hematology

Select article: Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple Myeloma

Retricted access

Review article

First published 2020-6

Selinexor: A First-in-Class Nuclear Export Inhibitor for Management of Multiply Relapsed Multiple Myeloma

Tim J. Peterson, Jennifer Orozco, Michael Buege

Annals of Pharmacotherapy

Select article: A phase 1 study of the safety,pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies

Open access

Research article

First published 2022

A phase 1 study of the safety,pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies

Jingshan Ho, Valerie Heong, Wei Peng Yong [...]

Therapeutic Advances in Medical Oncology

Select article: NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies

Open access

Research article

First published 2025

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies

Joan R. Choo, Santhiay Nathan Jeraj, Raghav Sundar [...]

Therapeutic Advances in Medical Oncology

Select article: Novel small-molecule therapies for myelodysplastic syndromes with IPSS-R ⩾3.5 in patients aged 60 or older: current landscape and challenges

Open access

Review article

First published 2025

Novel small-molecule therapies for myelodysplastic syndromes with IPSS-R ⩾3.5 in patients aged 60 or older: current landscape and challenges

Kehao Hou, Xue Dong, Wenyan Niu

Therapeutic Advances in Hematology

1
10 / page

Article type

Publication date

Subjects

Access